0
Over 500 cases of HCC studied from 1986-2022.
Ten or more tumor buds linked to high mortality.
Tumor budding identified as an independent risk factor for disease-specific mortality.
44.6 percent of surgically treated patients were bud-positive.
TSR showed no significant correlation with survival.
Detection sensitivity for tumor budding from biopsies was only 22 percent.
